Scientific publications

• Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.
  Prenafeta A, Bech-Sàbat G, Moros A, Barreiro A, Fernández A, Cañete M, Roca M, González-González L, Garriga C, Confais J, Toussenot M, Contamin H, Pizzorno. A, Rosa-Calatrava M, Pradenas E, Marfil S, Blanco J, Rica P.C, Sisteré-Oró M, Meyerhans A , Lorca C, Segalés J, Prat T, March R, Ferrer, L.
  ISCIENCE (2023), available here.
• Preclinical efficacy, safety and immunogenicity assessment of a vaccine candidate in a cynomolgus monkey model of SARS-CoV-2 infection.
  Confais J, Toussenot M, Ployart S, Bech-Sabat G, Roca M, Pizzorno A, Julien T, Rosa-Calatrava M, March R, Contamin H.
  Festival of Biologics, Nov 2-4, 2022 & Immunotherapies & Innovations for Infectious Diseases congress, November 23-24, 2022.
  Poster available here.
• Preclinical efficacy, safety, and immunogenicity in cynomolgus macaques of the PHH-1V COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.
  Moros A, Fernández A, Bech-Sabat G, Barreiro A, Garriga C, Pradenas E, Marfil S, Blanco J, Sisteré M, Meyerhans A, Confais J, Toussenot M, Contamin H, Pizzorno A, Rosa-Calatrava M, Prat T, Roca M, March R, Prenafeta A, Ferrer L.
  Spanish Society for Virology national congress, Sept 6-9, 2022.
• African Green Monkey model of SARS-CoV-2 infection shows mild lung pathology and viral replication in the airways.
  Confais J, Toussenot M, Julien T, Ployart S, Pizzorno A, Rosa-Calatrava M, Contamin H.
  Immunotherapies & Innovations for Infectious Diseases congress, 9-10^th December, 2020.
• Differential interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
  Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA.
  J Immunol. 2015 Aug 1;195(3):1034-43.
• Les PNH en infectiologie.
  Contamin H.
  4ème Séminaire EFOR (Network of Functional Studies in Model Organisms), 13-14 Feb 2013, Paris.
• Plasmodium falciparum infected squirrel monkeys (Saimiri sciureus): a non-human primate model for the assessment of antimalarial efficiency of drug candidates.
  Grandin C.
  12th European Primate Veterinarian (EPV) annual symposium, 27-28 Sept 2012, Lyon.
• Le singe écureuil Saimiri sciureus infecté par Plasmodium falciparum : un nouveau modèle pour l’évaluation de candidats antipaludiques.
  Grandin C.
  Consortium AntiParasitaire, 9-10 Feb 2012, Toulouse.
• Primates et paludisme : le dialogue évolutif entre hôtes et parasites.
  Contamin H.
  3ème Séminaire EFOR (Network of Functional Studies in Model Organisms), 9-10 Jan 2012, Paris.
• Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
  Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F.
  J Infect Dis. 2012 Jul 15;206(2):212-9.
• Experimental infection of squirrel monkeys with nipah virus.
  Marianneau P, Guillaume V, Wong T, Badmanathan M, Looi RY, Murri S, Loth P, Tordo N, Wild F, Horvat B, Contamin H.
  Emerg Infect Dis. 2010 Mar;16(3):507-10.
• Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.
  Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H.
  J Virol. 2009 Jun;83(11):5890-903.
• An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.
  Vigan-Womas I, Guillotte M, Le Scanf C, Igonet S, Petres S, Juillerat A, Badaut C, Nato F, Schneider A, Lavergne A, Contamin H, Tall A, Baril L, Bentley GA, Mercereau-Puijalon O.
  Infect Immun. 2008 Dec;76(12):5565-80. Erratum in: Infect Immun. 2009 Feb;77(2):926.
• Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey.
  Le Scanf C, Vigan-Womas I, Contamin H, Guillotte M, Bischoff E, Mercereau-Puijalon O.
  Microbes Infect. 2008 Apr;10(4):447-51.
• Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
  Callendret B, Lorin V, Charneau P, Marianneau P, Contamin H, Betton JM, van der Werf S, Escriou N.
  Virology. 2007 Jul 5;363(2):288-302.
• Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
  Lefeuvre A, Contamin H, Decelle T, Fournier C, Lang J, Deubel V, Marianneau P.
  Microbes Infect. 2006 May;8(6):1530-8.
• The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
  Heraud JM, Mortreux F, Merien F, Contamin H, Mahieux R, Pouliquen JF, Wattel E, Gessain A, de Thé H, Bazarbachi A, Hermine O, Kazanji M.
  Antiviral Res. 2006 Jul;70(3):132-9.
• Blood typing in Saimiri sciureus monkeys: influence of anti-red blood cell alloantibodies on Plasmodium falciparum parasitaemia in vivo.
  Michel JC, Behr C, Morales-Betoulle ME, Jouin H, Mercereau-Puijalon O, Contamin H.
  Microbes Infect. 2005 Jun;7(7-8):983-9.

• Assessment of the efficacy of aerosolized antibody-based therapies for respiratory diseases in relevant preclinical models.
  Dalloneau E, Confais J, Contamin H. Antibody Industrial Symposium, November 23 – 26^th, 2020.
• Pertinence des modèles primates non-humains pour l’aérosolisation d’immunothérapies.
  Contamin H., Verset M. Développement Préclinique des Immunothérapies 2018 (Journée MabDesign et LyonBioPôle), 24 Avril 2018, Lyon.
• Preclinical development of immunotherapies for infectious diseases: relevance of the Non-Human Primate.
  Verset M, Contamin H. Immunotherapies for Infectious Diseases Congress (I4ID) 2017, 11-12 December 2017, Lyon.
• Relevance of NHP models regarding aerosolization.
  Verset M et al. 8th Aerosolstorming Day, 29 May 2017, Paris.Aerosolstorming
• Development of a cynomolgus macaque model of infection with hRSV to evaluate therapeutic approaches.
  Blanc SC et al. Infectious Diseases Models for Innovative Therapies (IDMIT) Symposium 2016, 10 June 2016, Paris.IDMIT
• Development of a cynomolgus macaque model of infection with hRSV to evaluate therapeutic approaches.
  Blanc SC et al. Therapeutic Monoclonal Antibodies for Respiratoy Diseases (TMARD): current challenges and perspectives, 31 March-1 April 2016, Tours.
  TMARD
• Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors.
  Grandin C et al. Antiviral Res. 2016 Jan 19;125:58-62. ScienceDirect
• Differential interaction of the staphylococcal toxins panton-valentine leukocidin and γ-Hemolysin CB with human C5a receptors.
  Spaan AL et al. J Immunol. 2015 Aug 1;195(3):1034-43. jimmunol.org
• Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques.
  Grandin C et al. J Gen Virol. 2015 Apr 96(Pt 4): 782-792 vir.sgmjournals.org

• The PREMISE database of 20 Macaca fascicularis PET/MRI brain images available for research.
  Chalet L, Debatisse J, Wateau O, Boutelier T, Wiart M, Costes N, Mérida I, Redouté J, Langlois J.B, Lancelot S, Léon C, Cho T.H, Mechtouff L, Eker O.F, Nighoghossian N, Canet-Soulas E and Becker G. Nature, November 2023. (Online)
• Recombinant myelin oligodendrocyte glycoprotein (MOG) quality modifies evolution of EAE in macaques.
  Stimmer L, Confais J, Jong A, Verth J, Fovet  CM, Horellou P, Massonneau J, Perrin A,  Miotello G, Avazeri E, Hart B, Deiva K, Le Grand R, Armengaud J, Bajramovic J, Contamin H, and Serguera C.  Laboratory Investigation, August 2021. (Online)
• Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model.
  Di Cataldo V , Debatisse  J, Piraquive  J, Géloën  A, Grandin  C, Verset  M, Taborik  F, Labaronne  E, Loizon  E, Millon  A, Mury  P, Pialoux  V, Serusclat  A , Lamberton  F, Ibarrola  D, Lavenne  F, Le Bars  D, Troalen  T, Confais  J, Crola Da Silva  C , Mechtouff  L, Contamin  H,  A Fayad  Z, Canet-Soulas  E.
  Brain Communications, 2021 Apr 1;3(2):fcab064. (Online)
• PET-MRI nanoparticles imaging of blood–brain barrier damage and modulation after stroke reperfusion.
  Debatisse J, Eker O.F., Wateau O, Cho T.H , Wiart M, Ramonet D, Costes N, Mérida I, Léon C, Dia M, Paillard M, Confais J, Rossetti F,  Langlois J.B, Troalen T, Iecker T, Le Bars D, Lancelot S, Bouchier B, Lukasziewicz AC, Oudotte A. Nighoghossian N, Ovize M, Contamin H, Lux F, Tillement O, Canet-Soulas E.
  Brain Communications, Volume 2, Issue 2, 2020, fcaa193.
• A non-human primate model of stroke reproducing endovascular thrombectomy and allowing long-term imaging and neurological read-outs.
  Wateau O*, Debatisse J*, Cho T.H , Costes N, Mérida I, Léon C, Langlois J.B, Taborik F, Verset M, Portier K, Aggour M, Troalen T, Villien M, Makris N, Tourvieille C, Le Bars D, Lancelot S, Confais J, Oudotte A. Nighoghossian N, Ovize M, Vivien D, Contamin H, Agin V, Canet-Soulas E, Eker O.F.
  Journal of Cerebral Blood Flow and Metabolism, May 19, 2020 (Online).
• Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics.
  Thiollier T., Wu C., Porras G., Bezard E., Li Q., Zhang J., Contamin H.
  Animal Model Exp Med. 2018 Dec 4;1(4):314-321.
• Comparison of PET and MRI Estimation of Cerebral Perfusion using Multi Parametric PET-MR in a Non-human Primate Model of Stroke.
  Debatisse J., Makris N., Costes N., Verset M., Wateau O., Portier K., Aggour M., Langlois J.B., Tourvieille C., Le Bars D., Troalen T., Contamin H., Cho T.H., Canet-Soulas E. Joint Annual Meeting ISMRM-ESMRMB 2018, 16-21 June 2018, Paris (France).
• Comparison of PET and MRI Estimation of Cerebral Perfusion using Multi Parametric PET-MR in a Non-human Primate Model of Stroke.
  Debatisse J., Makris N., Costes N., Verset M., Wateau O., Portier K., Aggour M., Langlois J.B., Tourvieille C., Le Bars D., Troalen T., Contamin H., Cho T.H., Canet-Soulas E. 13th European Molecular Imaging Meeting (EMIM), 20-23 March 2018, Kursaal San Sebastian (Spain).
• Molecular determinants of barrier functions in Macaca fascicularis blood-brain interfaces.
  Strazielle N., Blondel S., Verset M., Robelet S., Contamin H., Ghersi-Egea J.F.
  12th International Conference on Cerebral Vascular Biology (CVB 2017), 28 November-1 December 2017, Melbourne (Australia).
• Inter-observer variability of image derived input functions for kinetic analysis of [15O]H2O PET in the nonhuman primate.
  Makris N.E., Costes N., Debatisse J., Langlois J.­B., Bouillot C., Villien M., Le Bars D., Wateau O., Verset M., Cho T.­H., Canet­-Soulas E. 13th Conference on Quantification of Brain Function with PET (BRAIN PET), 1-4 April 2017, Berlin (Germany).
• Preliminary analysis of multi-parametric PET/MRI in a non-human primate model of cerebral ischemia-reperfusion.
  Makris N., Debatisse J., Costes N., Langlois J.B., Villien M., Le Bars D., Portier K., Aggour M., Rioufol G., Wiart M., Ovize M., Wateau O., Contamin H., Berthezene Y., N., Vivien D., Barbier E., Verset M., Cho T.-H., Canet-Soulas E. 12th European Molecular Imaging Meeting (EMIM), 5-7 April 2017, Cologne (Germany).
• Safety evaluation and imaging properties of gadolinium-based nanoparticles in nonhuman primates.
  Kotb et al.Sci Rep. 2016 Oct 11;6:35053.nature.com
• Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson disease.
  Thiollier T et al. Synapse. 2016 Jun;70(6):231-9.
• Microdialysis in awake macaque to assess brain bioavailability.
  Thiollier T et al. Journées du GMP, 23-25 Oct 2015, Paris.
• Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer.
  Fruchon S, Mouriot S, Thiollier T, Grandin C, Caminade AM, Turrin CO, Contamin H, Poupot R. Nanotoxicology. 2015 May;9(4):433-41.
• Platform KINE C3 – A relevant technological method to assess brain bioavailability of new therapeutic compounds.
  Grandin C. 13th European Primate Veterinarian (EPV) annual symposium, 27-29 Sept 2013, Goettingen.
• Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.
  Barraud Q., Obeid I., Aubert I., Barrière G., Contamin H., McGuire S., Ravenscroft P., Porras G., Tison F., Bezard E., Ghorayeb I. PLoS One. 2010 Oct 13;5(10)
• Etude de la biodisponibilité intra-cérébrale de molécules thérapeutiques chez le modèle primate.
  Contamin H et al. XXIIIème Colloque de la Société Francophone de Primatologie (SFDP), 20-22 Oct 2010, la Baume-les-Aix.
• Development of a tri-compartmental pharmacokinetic platform to study the brain bioavaibility of innovative drugs: approach in the non human primate model.

Contamin H. 10th European Primate Veterinarian (EPV) annual symposium, 29 Sept-1 Oct 2010, Marseille.

• Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model.
  Di Cataldo V., Debatisse J., Piraquive J., Géloën A., Grandin C., Verset M., Taborik F., Labaronne E., Loizon E., Millon A., Mury P., Pialoux V., Serusclat A., Lamberton F., Ibarrola D., Lavenne F., Le Bars D., Troalen T., Confais J., Crola Da Silva C., Mechtouff L., Contamin H., A Fayad Z., Canet-Soulas E. Brain Communications, 2021 Apr 1;3(2):fcab064. (Online)
• Supervised clustering analysis for quantification of neuroinflammation using [11C]PK11195 PET in young and old controls, and atherosclerotic non-human primates.
  Debatisse J., Makris N., Di Cataldo V., Portier K, Verset M., Wateau O., Langlois J.B., Lamberton F., Ibarolla D., Lavenne F., Le Bars D., Troalen T., Contamin H., Cho T.H., Canet-Soulas E. TOPIM 2018, 21-26 January 2018, Les Houches (France).
• Supervised clustering analysis for quantification of neuroinflammation using [11C]PK11195 PET in young and old controls, and atherosclerotic non-human primates.
  Debatisse J., Makris N., Di Cataldo V., Portier K, Verset M., Wateau O., Langlois J.B., Lamberton F., Ibarolla D., Lavenne F., Le Bars D., Troalen T., Contamin H., Cho T.H., Canet-Soulas E. 13th European Molecular Imaging Meeting (EMIM), 20-23 March 2018, Kursaal San Sebastian (Spain).
• Markers of vulnerable plaques in Non-Human Primates under atherogenic diet.
  Di Cataldo et al. 2016 World Molecular Imaging Congress, 7-10 Sept 2016, New York.
  atherosclerosis-journal.com
• MR and PET/CT Imaging using to stratify cardiovascular risks in Non-Human Primates under atherogenic diet.
  Di Cataldo et al. 11th International Conference on Cerebral Vascular Biology, 6-9 July 2015, Paris.
• A minimally-invasive post-ischemic model of chronic heart failure in cynomolgus monkeys (Macaca fascicularis): clinical and imaging follow-up.
  Contamin H et al. Réunion ABCAL (Association des Biologistes Cliniciens pour Animaux de Laboratoire), 5-7 June 2013, Marcy l’Etoile.
• A novel minimal invasive closed chest myocardial ischaemia reperfusion model in rhesus monkeys (Macaca mulatta): improved stability of cardiorespiratory parameters.
  Portier et al. Lab Anim.2012 Apr;46(2):129-135. (Online)
• A minimally-invasive closed chest myocardial occlusion-reperfusion model in rhesus monkeys (Macaca mulatta): monitoring by contrast-enhanced ultrasound imaging.
  Contamin H et al.
  Int J Cardiovasc Imaging.2012 Mar; 28 (3): 531-542. (Online)
• Mise au point d’un modèle primate d’infarctus du myocarde par occlusion-reperfusion coronarienne.
  Mouriot S. XXVème Colloque de la Société Francophone de Primatologie (SFDP), 17-19 Oct 2012, Lyon.
• Establishment of a minimally-invasive post-ischemic model of chronic heart failure in cynomolgus monkeys (Macaca fascicularis).
  Drut A. 12th European Primate Veterinarian (EPV) annual symposium, 27-28 Sept 2012, Lyon.
• Effects of myocardial ischemia-reperfusion on cardio-respiratory parameters in closed chest monkeys during long term anaesthesia.
  Grandin C. 11th Joint Scientific Meeting (ESLAV, LAVA and ComVet AFSTAL), 26-28 Sept 2010, Toulouse

• Repair of full-thickness articular cartilage defects using IEIK13 self-assembling peptide hydrogel in a non-human primate model.
  Dufour A., Lafont M., Buffier M., Verset M., Cohendet A., Contamin H., Confais J., Rioult M., Perrier-Groult E., Mallein-Gerin F. Scientific Reports, 2021 Feb 25;11(1):4560. (Online)
  
• Repair of osteochondral defect in a non-human primate model using autologous chondrocyte-seeded hydrogels.
  Dufour A., Verset M., Cohendet A., Buffier M., Rioult M., Contamin H., Perrier-Groult E., Mallein-Gerin F. 2018 European Cells & Materials 13rd Conference, 25-28 June 2018, Davos.
• Regeneration of the cementum and periodontal ligament using local BDNF delivery in class II furcation defects.
  Jimbo R., Singer J., Tovar N., Marin C., Neiva R., Bonfante E.A., Janal M.N., Contamin H., Coelho P.G. J Biomed Mater Res B Appl Biomater. 2018 May;106(4):1611-1617.
• Use of autologous chondrocyte-seeded hydrogel to treat focal cartilage defect in non-human primate.
  Dufour A., Verset M., Cohendet A., Buffier M., Rioult M., Contamin H., Groult E., Mallein-Gérin F. 20èmes Journées Françaises de Biologie des Tissus Minéralisés (JFBTM), 21-23 Mars 2018, Monaco.
• Use of autologous chondrocyte-seeded hydrogel to treat focal cartilage defect in non-human primate.
  Dufour A., Verset M., Cohendet A., Buffier M., Rioult M., Contamin H., Groult E., Mallein-Gérin F. International Cartilage Repair Society 2018 14th World Congress, 9-12 April 2018, Macao (China). (Online)
• Comparisons of HR-MRI with μCT arthrography (μCTA) for the morphological assessment of non-human primate models of osteoarthritis.
  Perrier A.L., Chereul E., Grenier D., Taborik F., Abdallah M., et al. Nouvelles méthodologies en imagerie du vivant, Dec 2012, Lyon, France. pp.67 – 75. Download poster
  
• Morphological assessment of non-human primate models of osteoarthritis: Comparisons of HR-MRI with CT arthrography (CTA).
  Perrier A.L., Chereul E., Grenier D., Taborik F., Abdallah M., Chuzel T., Martin S., Magnier L., Contamin H., Beuf O. Conference: International Society for Magnetic Resonance in Medicine 2012, Melbourne, Australia.

• Développement préclinique des immunothérapies : apport des modèles PNH.
  Verset M., Mosca M., Panzuti P., Contamin H., Pin D. STAL. 2018 2e trimestre 46(2): 12-16.
• Preclinical development of immunotherapies for infectious diseases: relevance of the Non-Human Primate.
  Verset M., Contamin H. Immunotherapies for Infectious Diseases Congress (I4ID) 2017, 11-12 Déc. 2017, Lyon.
• Développement préclinique des immunothérapies : apport des modèles PNH.
  Verset M et al. 43ème colloque AFSTAL (Association Française des Sciences et Techniques de l’Animal de Laboratoire), 7-9 Juin 2017, Lyon.
• Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey).
  Contamin H., Loizon S., Bourreau E., Michel J.C., Garraud O., Mercereau-Puijalon O., Behr C. Immunol Methods. 2005 Feb;297(1-2):61-71.
• Sequencing and analysis of genomic DNA and cDNA encoding TNF-alpha in the squirrel monkey (Saimiri sciureus).
  Mérien F., Lavergne A., Behr C., Contamin H. Vet Immunol Immunopathol. 2003 Mar 20;92(1-2):37-43.

• Gestion du Primate Non Humain Isolé.
  Boudou G.
  32ème Rencontre de l’ATTE (Association des Techniciens de Toxicologie Expérimentale), 28-29 Sept 2017, Miserey.
• Intérêt de l’apport de litière dans les hébergements des PNH.
  Taborik F.
  30ème Rencontre de l’ATTE (Association des Techniciens de Toxicologie Expérimentale), 1-2 Oct 2015, Gidy.
• Concilier innovation scientifique et respect de l’animal : un enjeu pour la recherche préclinique – Exemple de la mise au point d’un siège à contention adapté au primate non humain.
  Taborik F et al.
  STAL. 2014 1er trimestre 40(1): 49-53.
• Techniques d’administration et de prélèvement intra articulaire chez le primate.
  Taborik F.
  29ème Rencontre de l’ATTE (Association des Techniciens de Toxicologie Expérimentale), 25-26 Sept 2014, Saint-Germain-Nuelles.
• Concilier innovation scientifique et respect de l’animal : un enjeu pour la recherche préclinique – Exemple de la mise au point d’un siège à contention adapté au primate non humain.
  Taborik F et al.
  39ème colloque AFSTAL (Association Française des Sciences et Techniques de l’Animal de Laboratoire), 9-11 Oct 2013, La Rochelle.
• Lavage broncho-alvéolaire chez le primate non humain.
  Paturet A.
  28ème Rencontre de l’ATTE (Association des Techniciens de Toxicologie Expérimentale), 26-27 Sept 2013, Porcheville.
• Prélèvement du LCR chez le primate non humain.
  Taborik F.
  28ème Rencontre de l’ATTE (Association des Techniciens de Toxicologie Expérimentale), 26-27 Sept 2013, Porcheville.
• Elaboration d’un programme d’animalerie conforme au référentiel AAALAC dans le cadre d’une animalerie primates.
  Grandin C et al.
  XXVème Colloque de la Société Francophone de Primatologie (SFDP), 17-19 Oct 2012, Lyon.
• Chaise de contention multifonction.
  Grandin C.
  Journée Com’Prim Optimiser l’utilisation des PNH en recherche de l’AFSTAL (Association Française des Sciences et Techniques de l’Animal de Laboratoire), 5 June 2012, Marseille.
• Le singe écureuil Saimiri sciureus infecté par Plasmodium falciparum : un nouveau modèle pour l’évaluation de candidats antipaludiques.
  Grandin C.
  Consortium AntiParasitaire, 9-10 Feb 2012, Toulouse.
• Concilier innovation scientifique et respect de l’animal : un enjeu pour la recherche préclinique.
  Grandin C et al.
  37ème colloque AFSTAL (Association Française des Sciences et Techniques de l’Animal de Laboratoire), 25-27 May 2011, Marne-La-Vallée.